B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Mubritinib

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Mubritinib, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

cediranib
2 shared targets
gefitinib
2 shared targets
neratinib
2 shared targets
erlotinib
2 shared targets
vandetanib
2 shared targets
canertinib
2 shared targets
Dasatinib
2 shared targets · score 45
alvocidib
2 shared targets
foretinib
2 shared targets
bosutinib
2 shared targets
Loading evidence profile...

This evidence profile for Mubritinib is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.